Adaptive Biotechnologies Corp (ADPT) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2017: $15.68M2018: $19.67M2019: $22.27M2020: $22.53M2021: $49.30M2022: $57.91M2023: $75.55M2024: $72.08M2025: $71.36M$71.36M
2017Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$71.36M-1.0%
2024$72.08M-4.6%
2023$75.55M+30.5%
2022$57.91M+17.5%
2021$49.30M+118.8%
2020$22.53M+1.1%
2019$22.27M+13.2%
2018$19.67M+25.4%
2017$15.68M